Dyadic International Stock

Dyadic International FCF per Share

The Free Cash Flow per Share of Dyadic International (DYAI) as of Aug 6, 2026 is -0.17 USD. In the previous year, Free Cash Flow per Share was -0.14 USD — a change of 28.92% (lower).

FCF per Share

-0.17USD

YoY

28.92%

Last updated:

Free Cash Flow per Share of Dyadic International is 2026 -0.17 USD. Free Cash Flow per Share of Dyadic International was 2025 -0.14 USD. It decreases by 28.92% lower compared to the previous year.
Access this data via the Eulerpool API

Dyadic International Stock analysis

What does Dyadic International do? The company Dyadic International Inc was founded in the Netherlands in 1979 and is now headquartered in Jupiter, Florida. The company is a leading global biotechnology company. Dyadic International specializes in the development and production of enzymes and proteins used in the production of foods, agricultural products, pharmaceuticals, and biopharmaceuticals. The company's business model is based on the use of proprietary technologies and know-how to optimize the production process of enzymes and proteins. Dyadic uses a platform technology called C1, which is based on a mold fungus and allows for the large-scale production of enzymes and proteins. The technology can be used in various ways, providing high flexibility to meet the needs of customers. One of Dyadic's key sectors is the agricultural industry. The company produces enzymes that increase the efficiency of ethanol production and contribute to the reduction of greenhouse gas emissions. Dyadic also works on the development of enzymes that improve the digestibility of animal feed and contribute to the overall health of animals. Another important area is the food industry. Dyadic produces enzymes used in the production of foods such as bread, cheese, beverages, and sweeteners. These enzymes improve product properties, such as shelf life and texture, resulting in higher quality and efficiency in production. Dyadic also operates in the biopharmaceutical industry. The company produces recombinant proteins used in the production of pharmaceuticals. The C1 technology allows for cost-effective production of proteins, particularly beneficial for generic and biosimilar manufacturers. One example of a Dyadic product in the biopharmaceutical industry is the antibody fragment Dyadic rFVIIa, used in the treatment of bleeding in patients with hemophilia. The C1 technology enables the production of the fragment in large quantities and high purity, contributing to cost-effective production. Overall, Dyadic has more than 70 partners and customers from various industries worldwide. The company works closely with its customers to develop and produce tailored solutions for their needs. Through the C1 technology and flexibility in application possibilities, Dyadic International Inc is an important partner for companies in different industries that rely on enzymes and proteins. The main message of the text is that Dyadic International Inc is a leading global biotechnology company specializing in the development and production of enzymes and proteins for various industries. Dyadic International is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Dyadic International stock

Free Cash Flow per Share of Dyadic International is -0.17 USD in 2026.

Free Cash Flow per Share of Dyadic International changed from -0.14 USD to -0.17 USD, representing a 28.92% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow per Share Dyadic International since 2006 – with annual values, charts, and detailed analysis.

FCF per share measures the free cash flow allocated to each outstanding share. It is a key metric for assessing shareholder value creation.

Access this data via the Eulerpool API

Cash Flow — Dyadic International

All Key Metrics — Dyadic International